Early Laparoscopic Cholecystectomy for Mild Gallstone Pancreatitis
NCT07931755, Not yet recruiting, Sohag University
Trial 9
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Early Laparoscopic Cholecystectomy for Mild Gallstone Pancreatitis | ClinicalTrials.gov |
| NCT number | NCT07931755 | ClinicalTrials.gov |
| Status | Not yet recruiting | ClinicalTrials.gov |
| Enrollment | 50 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | Sohag University | ClinicalTrials.gov |
| Conditions | Mild Gallstone Pancreatitis, Acute Pancreatitis, Gallstones, Cholelithiasis | ClinicalTrials.gov |
| Interventions | Early Laparoscopic Cholecystectomy | ClinicalTrials.gov |
| First posted | 2026-11-12 | ClinicalTrials.gov |
| Last updated | 2026-11-12 | ClinicalTrials.gov |
Registered outcomes 6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Number of Participants With Successful Early Laparoscopic Cholecystectomy Without Conversion or Major Complications | From date of surgery through 30 days postoperatively | Defined as the number of patients who successfully undergo and complete early laparoscopic cholecystectomy during the index admission without conversion to open surgery, intraoperative bile duct or vascular injury, or major postoperative complications (such as bile leak, hemorrhage, or intra-abdominal collection requiring reintervention) graded Clavien-Dindo grade III or higher | ClinicalTrials.gov |
| Secondary | Conversion Rate to Open Cholecystectomy | Intraoperatively | Percentage of patients requiring conversion from laparoscopy to open surgery and reasons for conversion. | ClinicalTrials.gov |
| Secondary | Operative Time | Intraoperatively | The duration of the surgical procedure is measured in minutes from the initial incision to final closure. | ClinicalTrials.gov |
| Secondary | Postoperative Morbidity Rate | Up to 30 days postoperatively | Incidence of postoperative complications, including wound infection, bile leak, intra-abdominal fluid collections, and hemorrhage. | ClinicalTrials.gov |
| Secondary | Length of Hospital Stay | Through hospital discharge, up to 14 days | Total number of postoperative days and total hospital admission days until discharge. | ClinicalTrials.gov |
| Secondary | Hospital Readmission Rate | Within 30 days after hospital discharge | Rate of unexpected hospital readmission related to pancreatitis, recurrent biliary events, or surgical complications. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)